Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
about
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic reviewThe European Hematology Association Roadmap for European Hematology Research: a consensus documentBeyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia.Efficacy and safety of eltrombopag in adult refractory immune thrombocytopenia.Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia.Is ITP a thrombophilic disorder?Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.Procoagulant profile in patients with immune thrombocytopenia.Increasing observation rates in low-risk pediatric immune thrombocytopenia using a standardized clinical assessment and management plan (SCAMP® ).New aspects on the efficacy of high-dose intravenous immunoglobulins in patients with autoimmune thrombocytopenia.Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura.Evaluation of platelet function in thrombocytopenia.Bleeders, bleeding rates, and bleeding score.IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity.Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopeniaBleeding management in pediatric patients.Clinical Significance of T-Cell Immunoglobulin Mucin 3 Expression on Peripheral Blood Mononuclear Cells in Pediatric Acute Immune Thrombocytopenia.Inappropriate prescription of low molecular weight heparins for thromboprophylaxis among older hospitalized patients.Successful treatment of bleeding with tranexamic acid in a series of 12 patients with immune thrombocytopenia.Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: comment.Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia.Re: Severe Primary Autoimmune Thrombocytopenia (ITP) in Pregnancy: a national cohort study Primary immune thrombocytopenia management during pregnancy. A French study.Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus
P2860
Q26826853-5ED876A4-8442-4B2C-B9CD-DA9D72EF04B4Q28830861-9EF746A2-A6FC-46B2-9AA6-FEB90B629B20Q30399669-BE71D664-321A-4FAE-9D87-8A1157ECC02DQ33409611-3203210B-1F58-4A1A-8269-00C17F78CAF9Q33415059-9CB58C97-CC3C-4F09-BEE9-802B66423BDBQ33421634-B9F496A7-A6B0-4EB8-8DFD-2CA14E4F7981Q33424357-FB7AA95F-179A-4371-9D65-855F7537983AQ33427394-44CD5CF5-60DC-421B-8434-0D5E81C962D3Q33431119-3BC945D8-51A9-428C-ACF8-8D9DF1D6B864Q33434822-2039083A-715B-411A-886F-8F852A0DFC20Q33436189-98564B66-9216-4D55-B0D4-CEE1E926513CQ33436298-DD4F81FE-E1F1-4D0D-8A3E-70636F9E8CB1Q33437797-D6D1419C-3797-43D2-8CFF-EC107FDD18C9Q33439931-2F4754CF-7B15-4747-B5F4-ABD4ACD02F46Q33440997-5AE816BC-6AC7-43E0-807F-5B1E059CF353Q38117731-99F7C76E-160C-4298-8F5E-4293A58D733EQ38328539-AA734206-BCD2-40AE-981C-305527B84C1EQ38624674-2CDF8F0F-4EF2-4D98-8C6D-FFB410CCCE7AQ42322058-905B91AE-BD86-4A35-A929-56E782C6E154Q45881678-983019DD-2837-4922-9411-529E48E88731Q46429214-0282B6A0-B8F3-4D63-9A53-3BB975F2AECCQ47308617-77DE7A84-E2A7-4CA1-9D02-4D15EC4C437FQ47927617-B2AC74E7-1F1A-44EB-A9EE-004A15D7EEE6Q48197104-20A763D1-43DD-45F9-B1B4-E63E8A6A3E5FQ48360142-F734FF0B-1DE7-45B7-8A40-B6E2CD253FA2Q49898824-701D240B-C5C8-4418-A748-598AED022167Q55221178-DEA7E3EB-7289-4E04-BF9E-17ED9B2FDEFDQ57652310-80F86FBA-12F6-4BFE-A6A3-13060120A6E8
P2860
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Standardization of bleeding as ...... he International Working Group
@ast
Standardization of bleeding as ...... he International Working Group
@en
Standardization of bleeding as ...... he International Working Group
@nl
type
label
Standardization of bleeding as ...... he International Working Group
@ast
Standardization of bleeding as ...... he International Working Group
@en
Standardization of bleeding as ...... he International Working Group
@nl
prefLabel
Standardization of bleeding as ...... he International Working Group
@ast
Standardization of bleeding as ...... he International Working Group
@en
Standardization of bleeding as ...... he International Working Group
@nl
P2093
P1433
P1476
Standardization of bleeding as ...... he International Working Group
@en
P2093
A. Greinacher
A. Newland
A. Tosetto
F. Rodeghiero
H. Liebman
I. Pabinger
M. G. Mazzucconi
M. Khellaf
P304
P356
10.1182/BLOOD-2012-07-442392
P407
P577
2013-04-04T00:00:00Z